Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiency
Jacob A. Myers(Brown University), Jeffrey S. Miller(Science Museum of Minnesota), Taylor A. DePauw(University of Minnesota Medical Center), Stephen C. Jameson(University of Minnesota Medical Center), Stephen D. O’Flanagan(University of Minnesota Medical Center), Frank Cichocki(University of Minnesota), Rih‐Sheng Huang(University of Minnesota), Jeremy M. Chacón(University of Minnesota), Martin Felices(University of Minnesota), Mihir Shetty(University of Minnesota), John R. Lozada(Twin Cities Orthopedics), Melissa Khaw(University of Minnesota), Laura E. Bendzick(University of Minnesota), Shee Kwan Phung(University of Minnesota), Justin H. Hwang(University of Minnesota), Juan E. Abrahante(University of Minnesota), Anna Weis(University of Minnesota), K. Maude Ashby(University of Minnesota Medical Center)
Cited by 4
Related Papers
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
|Blood|2013|537
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
|Blood|2018|406
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
|Cell stem cell|2021|153
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes
|The Journal of Experimental Medicine|2021|117